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Abstract
Traumatic Brain Injury (TBI) is a global health challenge, with over 4.6 million confirmed
cases annually in North America alone. Mild traumatic brain injuries (mTBIs) are the
most common and make up approximately 81% of all TBI diagnoses worldwide [1].
Studies indicate that 10–15% of patients suffer from trauma induced symptoms (i.e.
headache, loss of balance, cognitive impairments, fatigue, and mental health/affective
disorders) as far as 1 year post injury [2]. Prediction and management of these posttraumatic sequalae is complicated by a lack of symptom associated neuroimaging
findings. In spite of a “prominent distribution” of frontotemporal WMHs in pediatric
subjects with mTBI, a 2016 study (N=72) by Bigler et al. found no association between
unique changes in cortical thickness and WMHs after statistical correction for multiple
comparisons. This retrospective study will investigate the associations between cortical
thinning, white matter hyperintensities, and clinical outcomes in a large (N=147) and
neurodevelopmentally diverse (18-40 years-old) group of subjects diagnosed with mTBI.
Regional (Frontal Lobe, Temporal Lobe, Occipital Lobe, Parietal Lobe, and Cerebellum)
volumetric and WMH data was obtained for all 147 patients. Assessment of image finding
correlation showed that white matter hyperintensities did not consistently coincide with
cortical thinning as defined by the NeuroQuant normative percentile values. Intervalcensored analysis revealed statistically significant associations between positive WM
status and longevity of post-concussive cognitive deficits (p<0.024).
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I.

Introduction

Mild Traumatic Brain Injury (mTBI)
Traumatic brain injury (TBI) is a multifaceted and widespread condition known to affect
at least 2% of the US population. Broadly defined as an alteration in brain function or
brain pathology caused by an external force, TBIs are clinically described as either mild,
moderate, or severe [3, 4]. Mild traumatic brain injury (mTBI), also referred to as a
concussion, is the most common type of acute brain injury, making up approximately 81%
of all TBI diagnoses worldwide [4]. In recent years, mTBI has been branded a “silent
epidemic” by experts due to persisting cognitive, behavioral, and motor deficits
experienced by 10-15% of concussed individuals [5]. mTBIs can occur in a number of
ways, and the extent to which mechanism of injury modifies image findings and
symptomatology is not known. Studies on mTBI commonly include patients with a
history of motor vehicle collisions [1, 6], sports injuries [6-8], and even combat related
blast injuries [9, 10] . The precise structural/functional changes that cause an mTBI are
not yet known, but it is known that any deposition of mechanical force in the brain may
damage neurons, and disrupt the patency of neurological structures [11].

There is a decided lack of evidence-based diagnostic criteria for mTBI. This is due to
minimal interdisciplinary consensus on how to define, identify, or categorize traumatic
brain injuries in a quantitative capacity [2]. A recent survey found that in the United
States, less than half of level I trauma centers adhere to a standardized protocol for the
evaluation or treatment of mTBI [12]. At present, mTBIs are clinically described as the
aggregate of post-concussive somatic and neuropsychological symptoms. Somatic
symptoms refer to any non-psychological functional complications induced by brain
1

trauma, such as headaches, fatigue, dizziness/difficulty balancing, and abnormal sleep
patterns. Neuropsychological (sometimes referred to as neurobehavioral) sequelae
include cognitive deficits and anxiety/mood disorders. Post-traumatic cognitive
impairment, anxiety, and depression are particularly well described clinically and
experimentally [2, 13-17]. Cognitive deficits following mTBI are common and may even
occur without any posttraumatic amnesia or loss of consciousness. In this context,
cognitive deficits include any combination of impaired attention, working memory
and/or executive decision-making skills. Persistent post-concussive cognitive deficits are
frequently accompanied by increased anxiety, irritability, or depressive tendencies in
human subjects [14, 18, 19]. Nearly 100% of all mTBI patients report some degree of
neuropsychological impairment 0-3 months post-mTBI, with a small percentage
exhibiting persistent injury related complaints beyond 12 months post injury [14]. The
mechanism by which these brain related sequalae are related to mild traumatic brain
injury remains poorly understood [13, 17, 20].

Not all mTBI patients present with image findings that are detectable via conventional
imaging sequences and radiological interpretation. Even studies utilizing more
sophisticated imaging modalities have yielded minimal consensus on pathologic image
findings in mTBI. The absence of objective image findings limits clinical evaluation to
neuropsychological testing. There is great interest in establishing a more quantitative
taxonomy of TBI, particularly through non-invasive methods like advanced medical
imaging, which allows for acquisition of characteristic and quantitative data.
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Diffuse Axonal Injury in mTBI
Head trauma is known to cause diffuse shearing (tearing) of axons as the brain shifts and
rotates inside the skull. Axons are very thin, sometimes even thinner than a human hair,
and can range in length from a few millimeters to over a meter along the spinal cord [6].
From a functional perspective, the axon serves as a neurological impulse highway,
transferring electrical signals from the neural cell body to a synapse, where they are
converted into chemical signals called neurotransmitters [21]. A visual representation of
a neuron is shown in the figure below.

Figure 1: Anatomy of a nueron. Open access image courtesy of The University of Sydney
School of Medicine

The longer the axon, the more vulnerable it is to rotational or lateral shearing, and as such
trauma associated axonal injuries are commonly described in the white matter tracts of
the corpus collosum, the largest, most well-defined tract in the brain connecting the two
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hemispheres [5, 10, 22]. Clinically, this damage is referred to as diffuse axonal injury
(DAI). DAI is most commonly described on imaging in moderate/severe TBI but is known
to occur across the full spectrum of traumatic brain injuries [22]. Animal studies show
that DAI are important pathological features of brain injury and are important
modulators of symptomological outcomes [23, 24]. Image manifestation of DAI varies
proportionately with TBI severity and may appear as; hemorrhagic sites in CT or MRI
scans, increased signal on diffusion weighted sequences, or as white matter
hyperintensities (non-hemorrhagic shearing) (WMHs) on FLAIR/T2 weighted MRIs or
even on Diffusion Tensor Imaging in the form of low fractional anisotropy (FA) values.
These modalities differ in terms of what they measure and how they work but are all
highly sensitive to structural changes in white matter. Fluid-attenuated inversion
recovery (FLAIR) imaging, a post-processed T2 MRI sequence set to null fluid signals, is
commonly used in mTBI injury assessment. Figure 2 contains two representative images
of a WMH on both the FLAIR and conventional T2 sequences.

4

Figure 2: FLAIR (1A) and conventional T2 MRI (1B) showing two subcortical WMHs
at grey-white matter junction in the left anterior frontal lobe of a 22 year old female
diagnosed with mTBI.

In addition to its clinical utility, FLAIR has proven especially useful in the expansion of
TBI classification and taxonomy, revealing quantitative neuroimaging findings predicting
unfavorable recovery in ~30% of a large (N=135) and diverse patient population
diagnosed with mTBI [27]. Many studies have sought to characterize the relationship
between white matter lesions and clinical outcomes following mTBI, and have limited
conclusions on the association between WMH and post-concussive symptoms [6, 11, 18,
25]. Shetty et al. reported that while white matter abnormalities occurred at a higher rates
in mTBI patients than in controls, direct comparison was limited by differences in
5

imaging technology, and recommended follow up investigation [25]. Chung et al. noted
that since non-hemorrhagic DAIs frequently occur concomitantly with hemorrhagic
lesions (HDAI), it is difficult to determine the specific contribution of non-hemorrhagic
DAIs (manifesting as WMHs) to clinical outcomes [11]. To study the specific relationship
between non-hemorrhagic WMHs and mTBI, all patients with image evidence or clinical
history of hemorrhaging were excluded from analysis.

Recent studies indicate that DAI is a major pathologic event across the full spectrum of
TBI including concussion [15, 23, 26], and correlates with persistent cognitive and verbal
memory impairments after mTBI [26, 27]. Advances in diffusion tensor imaging and post
processing methods have identified large injury prone WM tracts reaching through
cortical regions of the brain, namely the corona radiata (CR) and cerebral peduncle (CP)
[28]. Diffusion Tensor Imaging studies focusing on non-hemorrhagic DAI are
inconclusive with regard to their impact on clinical outcomes, with some studies finding
a positive correlation between white matter changes and patient symptomology [29], and
others finding no apparent correlation [11, 30]. This study will not consider the impact of
WMH or cortical volume loss alone, but will instead focus on the impact of WMH in
relation to cortical regional volume to see how two subtle imaging findings may be used
in conjunction to predict symptom presentation following mTBI.

Cortical thinning in mTBI
By definition TBIs damages brain tissue. If the neuronal damage is sufficient to induce
neuronal apoptosis, this damage may manifest as decreased regional brain volume. Some
studies have hypothesized that atrophy of the cerebral cortex, frequently referred to
6

‘cortical thinning’, could serve as a quantitative biomarker in mTBI clinical assessment.
Most of these studies have shown trauma associated patterns of cortical thinning, though
these patterns are variable between studies [31-33]. Two pediatric studies have described
regional and whole-brain atrophy in the sub-acute (0-4 months) phase post-mTBI when
compared to age and sex matched controls [8, 34]. The 2008 study by Merkley et al. also
reported a relationship between cortical thinning and reported deficits in working
memory [34]. These pediatric studies indicate that cortical thinning may be a temporal
pathologic feature in mTBI and could serve as a complimentary measure in mTBI
diagnosis/assessment. Like WMH formation, cortical thinning is known to be an age
associated phenomenon and is often seen alongside WMH development in elderly people
[35]. To minimize a possible age-related bias in the findings, I have preferentially selected
subjects between 18 and 40 years old, for whom cortical atrophy is unlikely to be agerelated.
The precise mechanism by which mTBI influences cortical atrophy remains unclear, with
current studies yielding significant regional variability and inconsistent results between
chronic and acute mTBI patient populations in the level of cortical atrophy described [33,
36]. It is thought that regional variability of cortical atrophy may be due to mechanism of
brain injury, since different kinds of force deposition yield different and distinct damage
patterns [37]. This is substantiated by the fact that inter-patient regional variability of
cortical atrophy is reduced among patient populations with the same mechanism of injury
[33, 38]. There is some variability in patient demographics, however it is worth
mentioning that 78% of patients in this dataset were injured in motor vehicle collisions
(MVCs). From a clinical perspective this may be seen as convenient, since MVCs are
among the leading causes of mTBI worldwide [1]. However, this does introduce variability
7

in terms of injury mechanics. No conclusions on the association between traumatic force
vectors and cortical thinning can be made from this data. Several studies have shown a
positive correlation between regional cortical thinning and severity of cognitive and
behavioral symptoms in cases of moderate and severe TBI [34, 39, 40]. While this
association does not necessarily suggest a causal relationship, each of these studies
recommended further inquiry into cortical thinning as a potentially pathological event in
mTBI. The continued investigation of functionally relevant changes in regional brain
volume could lead to improved diagnosis and treatment of mTBI patients.

8

Preliminary Findings
Cortical volume and asymmetry in the 5 major lobes of the brain of 250 mTBI patients
were compared to age and gender matched controls in the Neuroquant normative
database. Correlation between symptom longevity and normative volumetric percentiles
was tested using a semi-parametric interval-censored survival analysis, shown in the table
1 below.

Region
Cerebellum
(Norm %)

Frontal Lobe
(Norm %)

Occipital Lobe
(Norm %)

Parietal Lobe
(Norm %)

Temporal Lobe
(Norm %)

Symptom
Headache
Balance
Cognitive
Anxiety
Headache
Balance
Cognitive
Anxiety
Headache
Balance
Cognitive
Anxiety
Headache
Balance
Cognitive
Anxiety
Headache
Balance
Cognitive
Anxiety

SE
2.44
4
5.14
7.91
0.28
0.3
0.26
2.24
0.28
0.27
0.28
3.22
0.36
0.31
0.3
0.47
0.25
0.31
0.22
1.21

z
Value
-0.1
-0.1
-0.2
-1.4
-0.8
-0.856
-0.7
-0.4
-1.8
-1.7
-2.7
-0.5
-1.9
-0.7
-0.478
-23.7
-1.7
-1.9
0.3
-0.4

p
Value
0.893
0.902
0.832
0.165
0.432
0.3923
0.499
0.723
0.071
0.086
0.008
0.001
0.063
0.494
0.6326
0
0.084
0.063
0.776
0.662

Table 1: Association between imaging findings and symptom outcome. Statistically
significant associations between norm percentile and symptom longevity are bold.
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Patients in the bottom tenth percentile in occipital or parietal volumes exhibited cognitive
deficits (p=0.008) and anxiety (p<0.001) lasting longer than patients showing higher
occipital or parietal percentile volumes. Based on this preliminary analysis, occipital and
parietal lobe volume appear to associate with persistent anxiety and cognitive deficits in
mTBI subjects. I hypothesize that WMHs and cortical atrophy may co-associate and
independently correlate with unfavorable clinical outcomes in a cohort of subjects (18-40
years-old) diagnosed with mTBI. To test my hypothesis I will assess the statistical
association between the two image findings, and between each image finding and
symptom incidence/longevity.
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II.

Background

White Matter and the Cerebral Cortex
White matter (WM) lies beneath the gray matter cortex in an area known as the medulla
and is composed principally of myelin coated nerve fibers referred to as axons. These
axons connect the neurons of the brain, ultimately allowing the brain to function as an
advanced electrical circuit. The circuit is complete with electrical insulation called
‘myelin’ that coats axons and gives white matter its characteristic color. White matter is
essential for normal cognitive function and psychological normalcy [18, 41]. Myelin is
essential for high-speed transmission of electrical impulses, and damage to it can impair
conduction and consequently, sensory, motor, and cognitive functions. Bundles of white
matter neurons, referred to as “tracts”, connect the functional regions of the brain.

The cerebral cortex is historically defined as the outermost 2-3 mm of neural tissue.
Comprised primarily of dense gray matter, the cortex contains 10-14 billion neurons and
makes up 40% of the brain’s total mass [4]. This region gives the brain its ‘wrinkly’
appearance, consisting of peaks called gyri, and valleys called sulci where approximately
two thirds of the cortical surface area is buried. The thickness of the cortex is not uniform
but is thicker over gyri and thinner over sulci [32]. Divided lengthways into two cerebral
hemispheres by the corpus callosum, the cerebral cortex is typically described in terms of
five regions: frontal, parietal, temporal, occipital, and cerebellar [8, 32, 42].
Advancements in neuroscience have shown that most brain functions rely on complex
information highways spanning many different regions of the brain, with the lobes of the
brain responsible for varying functions [35].
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The frontal lobe is positioned anterior to the parietal lobe, directly behind the forehead.
The neurons in the frontal lobe are different from those in other cortical regions in that
they produce a critical neurotransmitter called dopamine. Attention span, short-term
memory, planning, and motivation are all cognitive processes known to rely on
dopaminergic pathways. As such, the frontal lobe is considered the primary modulator of
executive functions such as emotional regulation, decision making, task prioritization,
and reward motivated behavior [43]. Neuropsychological issues relating to frontal lobe
trauma have been extensively documented in the literature [8, 35, 43]. One of the earliest
recorded examples of neuropsychological changes following frontal lobe trauma dates
back to 1848 when railyard worker Thomas Gage attempted unsuccessfully to set off a
controlled explosion. A spark from an iron tamping rod prematurely ignited the blasting
powder, resulting in the penetration of his frontal lobe by a 3-foot-long, 14-pound metal
spike. The iron rod obliterated much of his left frontal lobe, but incredibly, his wounds
were non-fatal. Gage regained all cognitive and motor skills and within a year and
returned to work on the railroad. However, his physician, friends, and family noted
dramatic changes to his personality, describing him as more primal, fitful, and irreverent
[44]. While obviously an extreme and antiquated case, recent studies also indicate that
less severe damage to the frontal lobe may be accompanied by personality changes,
behavioral disinhibition, and generally uncharacteristic behavior [8, 35, 43].

Posterior to the frontal lobe is the parietal lobe. The parietal lobe is a hub of tactile
processing, receiving signals that in turn stimulate the sensations of touch, temperature,
and pain. The parietal lobe is also the primary source of visuospatial processing, which
affects general spatial awareness as well as reading, writing, and mathematic ability [15,
12

35]. Trauma to the parietal lobe may result in a series of cognitive changes known as
Gerstmann's Syndrome, characterized by diminished perception of language, difficulty
writing, difficulty with mathematics, and left-right confusion [45]. The impact of mTBI
on parietal lobe volumetrics or functionality is not well understood, though it is
reasonable to assume that post-concussive cognitive deficits may be due in part to damage
and functional alternation of the parietal lobe.

The temporal lobe, located anteroinferior to the frontal lobe, is heavily involved in the
processing of auditory signals, language recognition and visual memory (particularly of
facial features) [32, 35]. Moderate to severe damage to the temporal lobe is known to
inhibit recollection of visual stimuli. Neuropsychological tests have confirmed that
patients with inhibited visual memory do not have reduced perception of visual stimuli
and can describe faces and objects in real time. One possible explanation for this
phenomenon is that that post-traumatic modification of visual memory results from
interruption or modification of signal processing in the temporal lobe [46].

The occipital lobe is the most posterior region of the cerebral cortex and serves as the
major visual processing center of the brain [35]. The occipital lobe is unique in that
physiologists have been able to successfully and repeatedly map function sub-regions of
the occipital lobe using electrode stimulation and functional MR imaging (fMRI) [47].
Apart from its comparatively robust functional characterization and importance in visual
processing, the occipital lobe is of particular interest in mTBI due to it’s position at the
rear of the skull. Many mTBIs can be described as ‘coup contrecoup’ injuries, meaning
that damage occurs both at and directly opposite the site of original insult. For example,
13

motor vehicle collisions, frequently result in whiplash damage to the occipital lobe [4].
The term ‘whiplash’ is often used interchangeably with ‘coup contrecoup’ but may also
refer to injuries of the cervical vertebrae and paraspinal muscles. When examined via
perfusion imaging, patients reporting “whiplash” due to front-end collisions exhibited
significantly reduced blood flow to the occipital and temporal lobe when compared to
non-trauma control groups [48].

The cerebellum, an important processor of signals traveling via the spinal cord, contains
the cortex which regulates the processes of balance and proprioception [32]. While not
responsible for the initiation of movement, the cerebellum does utilize sensory feedback
from the peripheral nervous system to fine tune the precision, timing, and coordination
of motor functions [49]. Damage to the cerebellum is most frequently accompanied by
persistent lack of equilibrium, manifesting clinically as difficulty walking and/or
balancing. Subjects will often try to compensate for this lack of balance with an ungainly
stride and/or a widened stance [50].

Symptomatology of mTBI
Although exact percentages vary depending on the author, 10-15% of mTBI patients
experience severe post-concussion symptoms lasting months or even years post injury [1,
51]. The aggregate of these symptoms is often referred to as post-concussion syndrome
(PCS) [5]. Diagnostic criteria for PCS is defined in the International Classification of
Diseases (ICD)-10 manual, as well as the Diagnostic and Statistical Manual of Mental
Disorders (DSM)-IV [52]. However, both definitions suffer from a lack of measurable
diagnostic criteria, relying primarily on assessment of self-reported symptoms and details
14

relating to injury. Many studies attempting to establish a more robust taxonomy of PCS
are inconclusive, citing inconsistent coincidence of symptoms, lack of quantitative
biomarkers, and minimal consensus on how persistent non-specific symptoms relate to
trauma. The subjective definition of post-concussion syndrome, the low specificity of PCS
symptomatology, and the significant symptomatic overlap with more thoroughly
documented neurological and psychiatric conditions render the term PCS of minimal
utility in both clinical and research environments [53-55].

Interval-Censored Statistics
Interval censoring is a form of survival analysis used to analyze incomplete or temporally
non-uniform datasets. More broadly interval censoring is a technique that can be used
when a variable (or multiple variables) of interest are known to change at a point during
an interval of time, but cannot be localized to any single discrete time point. This method
is defined arithmetically by the formula below:

T≡ I = (L, R]

In the above equation take ‘T’ to be the survival time of some variable of interest,
defined by the interval ‘I’.

In this study I am assessing the "survival time" of the previously described seven postconcussive symptoms. When T is interval-censored we use I = (L, R] to define the interval
measuring time T. In this formula () is used to indicate an open interval while [] means
the interval is closed. For example, the interval (96, 209] defines the set of all numbers
15

between 96 and 209 excluding 96 and including 209.) Our limit "L" is the number of
days post injury that symptoms were reported. The limit "R" is defined as the number
days post injury that improvement or resolution of a previously documented symptom
was reported. Additional censoring can be provided in cases where either L = 0 or R = ∞.
These

intervals

are

described

as

left

16

and

right

censored,

respectively.

III. Materials and Methods
Subjects
All data was obtained from a database of 400 mTBI patients following IRB approval. All
subjects were diagnosed with mTBI by the same board-certified neurologist specializing
in head trauma and received neurological consultation/imaging no more than 6 months
post-concussion. Demographic data was obtained from clinical reports and input into a
deidentified patient data sheet prior to analysis. Exclusion criteria were extensive and
included: history of demyelinating disease, cerebrovascular accident, head trauma,
chronic epilepsy, brain surgery, cerebral contusions, hemorrhagic diffuse axonal injury
(DAI), intracranial hemorrhaging, cerebral vascular malformations, cavernoma, or brain
tumors. Studies suggest that clinical outcomes following mTBI are likely age dependent
[25, 56], and that fully neuro-developed adults report higher symptom severity scores
than their younger counter parts [25]. Similarly, WMH formation is an age associated
phenomenon. To increase sensitivity of this analysis, all patients over the age of 40 were
removed from the dataset, and remaining subjects were separated into over/under 30year-old subgroups. The age cutoff was set at 30 for two main reasons: to account for the
completion of neurodevelopment and to maintain statistical power. The 2008 study
“Microstructural maturation of the human brain from childhood to adulthood” describes
two important frontotemporal connections (the cingulum and the uncinate fasciculus)
which by age 25 years have still not reached full developmental maturity [57]. This
suggests that neurodevelopment between the frontal and temporal lobes may not fully
complete until after 25 years of age. The cutoff of 30 provides consideration for
neurodevelopment while also retaining more statistically comparable samples sizes
(Cohen’s d: 0.45 vs 0.88) than a cutoff of 25. After exclusions, 147 mTBI patients
17

remained for subsequent analysis. Patient demographics of white matter subgroups are
defined in table 2.

No.

0 WMH

1 WMH

>1 WMH

88

25

34

(59.9%)

(17.0%)

(23.1%)

(29.9, 5.61)

(31.0, 6.98)

[20,40]

[18-39]

Subjects

Age
(Mean, SD)

(28.6, 7.5)

[Min, Max]

[19-40]

Sex
(Female)

28

13

(32.94%)

(38.24%)

18
(52.94%)

Table 2: Patient demographics of 147 subjects diagnosed with mTBI, sorted based on
WM subgroups (0 WMH: Patients with zero WMHs, 1 WMH: Patients with a single
WMH, >1 WMH: Patients with multiple WMHs)

Most of the patients in this cohort were involved in motor vehicle collisions. A breakdown
of common causes of injury in this civilian mTBI cohort is provided in table 3.
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0 WMH
Sex

1 WMH

>1 WMH

28

32.94%

13

38.24%

18

52.94%

4

4.71%

2

8%

1

0.43%

1

1.18%

1

4%

2

5.89%

77

83.53%

22

88%

29

85.29%

1

1.18%

0

0

2

5.89%

4

4.71%

0

0

0

0

(Female)
Cause of Injury
(Assault)
Cause of Injury
(Fall)
Cause of Injury
(MVC)
Cause of Injury
(Falling Object)
Cause of Injury
(Unknown)

Table 3: Injury demographics of 147 subjects diagnosed with mTBI, sorted into WMH
subgroups
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Subjects in this mTBI cohort are non-combatant, non-athlete civilians all of whom were
receiving consultation due to ongoing litigation relating to their injury and the severity of
their symptoms. One recent meta-analysis found litigation to have a ‘moderate effect’ on
clinical outcomes in TBI patients [58]. However two focused review articles found
minimal effect on cognitive deficits and headaches in litigants versus non litigants [59]
with many patients continuing to report post-traumatic headaches well after litigation
resolution [60].

Symptomatology
Symptom longevity is calculated from the date of injury to the time when improvement
or resolution (both referred to as ‘improvements’ hereafter) were reported during a visit
to the physician. Developments in post-concussive symptomological outcomes were
noted at each neurological consultation/follow-up. Studies examining symptom
incidence and outcomes following mTBI frequently deploy the term “symptom” to mean
any self-reported somatic/neuropsychiatric change experienced after a concussion [5, 9,
61, 62]. Incidence and resolution of seven common post-concussive symptoms were
obtained via a retrospective neurological consultation review. In accordance with recent
literature, seven symptoms were selected for consideration in this study: headaches,
balance issues, cognitive deficits, fatigue, anxiety, depression, and emotional lability.
[8,12,29].

Headaches were self-reported and assessed qualitatively by the neurologist and
documented in clinical reports. Balance issues were broadly defined as reduced steadiness
when walking, sitting, standing or resting. Common patient descriptions of balance deficit
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included ‘unsteadiness on the feet’, ‘feeling of falling’ and ‘coordination problems’.
Balance issues were assessed by the neurologist using a standard confirmatory physical
exam called the Romberg test for balance. For the purpose of this study, cognitive deficits
were defined as any impairment in attention, learning, memory, speaking, or frontal
executive functions [15]. Self-reported cognitive deficits were clinically assessed via AO
Mental Status Test, designating an alert and oriented score from 1-4 for each patient.
Neuropsychological symptoms including anxiety, depression and emotional lability were
diagnosed in accordance with DSMV diagnostic criteria. [13] Patient cognitive status was
assessed via AO Mental Status Test and were assigned an alert and oriented score from
times 1 to times 4. Patients describing anxiety and/or depression were evaluated via the
Beck index and provided scores from 0 to 63. Patients who reported loss of consciousness
(LOC) were evaluated and assigned scores via the protocol defined in the Glasgow Coma
Scale.

Imaging
Patients underwent an MRI protocol with either a 3.0 Tesla Signa HDxt MR system or a
3.0 Tesla Siemens system, both equipped with an 8-channel head coil. On the GE magnet,
slice thickness of 4.0 mm with 4.5 mm gap was performed, on the Siemens, a 2.2 mm
thickness with a 2.2 mm gap was performed. T2 FLAIR images were used for
quantification of white matter lesions using Inteleviewer DICOM viewer. WMH were
distinguished from fluid filled foci (dilated perivascular spaces) by dual confirmation on
T2 and FLAIR imaging sequences. Lesions were counted and then categorized by their
cortical region. Volumetric analysis was performed utilizing 1.2 mm GE thickness and 0.9
mm Siemens T1 weighted imaging as per NeuroQuant technical specifications.
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NeuroQuant volumetric software
NeuroQuant is an FDA approved neurovolumetric software which obtains regional brain
volumes from ultra-thin (~1 mm slice thickness) MRI images via an automated voxel
intensity analysis. In addition to providing raw volumetric output, NeuroQuant also
compares regional volumetrics to their normative database and provides normative
percentile values accounting for subject age, sex, and intracranial volume (ICV).
NeuroQuant has been used in both research and clinical environments to aid in the
diagnosis of brain injury and neurodegenerative disease. An example of a NeuroQuant
processed MRI is provided in the figure below.

A

B

C

Figure 3: Representative image of a sagittal, coronal, and axial T1 MRI of a 24-yearold male diagnosed with mTBI. Images were processed using NeuroQuant 3.0 (Note:
that in the above image slices each neuroanatomical sub-region is defined with a
different color).
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Statistical Analysis
To prove or disprove my hypothesis, I will need to first examine the correlation between
imaging findings for WMHs and cortical thinning. A Spearman rank correlation is well
suited to characterize this correlation, as it is a non-parametric correlation test that does
not carry any assumptions about the distribution of the data and is considered the most
accurate method of rank correlation analysis provided both datasets are at least ordinal.
The Spearman correlation does assume that scores on one variable must be monotonically
related to the other variable, which essentially means that any correlation (positive or
negative) between the two data groups is either entirely nonincreasing or nondecreasing.
For good measure, Spearman’s Rho and Pearson’s correlations will also be determined
using excel and used to examine the association between WMHs and cortical atrophy.

A Fisher’s exact test was used to assess the independent association between sex, age,
cortical atrophy, WMH status and symptom presentation/resolution. Comparisons
between defined subgroups were also made using a Fisher’s exact test for each symptomcharacteristic pair. The Fisher’s exact test was chosen over a chi-square test for two
reasons; Fisher’s exact test does not make any parametric assumptions about the data
distribution, and it is more sensitive to datasets with frequently occurring low (near 1)
values in each cell. Cortical atrophy positive patients were defined as having any lobular
volume in the 1st-25th percentile after NeuroQuant volumetric analysis. White matter
status was defined and analyzed in two ways. The first method dichotomization sorted
patients into a simple WMH positive or negative group. The second method
dichotomization separated patients with a single WMH from those with multiple WMHs.
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Independent variable models for sex, age, cortical atrophy and WMH status were
estimated separately for each post-concussive symptom. Standard errors (SE) were
derived from bootstrapping (100 samples). Differential symptom persistence between
stratified subgroups were tested by using the bootstrapped standard errors to form zscores. Analyses were conducted in R 3.5.1 software with the ‘icenReg’ package.

Many patients never reported improvement or resolution of symptoms. In such cases, the
data will be right-censored, which means that the symptom might improve at some future
time, but it had not improved by the date of the last visit to the physician. This analysis
assumes that symptom abatement or resolution is equally probable across the interval of
time between two appointments expressed by (L, R], where ‘L’ is the physician visit where
the symptom was last reported, and ‘R’ is the visit where improvement/resolution was
reported. This data censoring allows for statistical consideration of variable time between
injury and consultation. Data that are both interval-censored and right-censored statistics
are relatively common in medical studies, and can account for the uncertainties of this
retrospective clinical dataset [30]. Each patient in the analysis will be counted only once
for the analysis, with the uncertainty associated with the elapsed time between visits
serving as the maximum likelihood estimate of the survival function.

Limitations
All data is obtained retrospectively and is analyzed in the absence of a control group. All
findings and results in this analysis will need to be verified using longitudinal follow-up
studies with proper control groups and larger sample sizes. Subjects could not be screened
for certain comorbidities such as hypertension and pre-existing headaches/migraines
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with the clinical data available. Hypertension and migraines are particularly important
within the context of WMHs, with which they are both known to associate [63].
Neurological examination and subsequent imaging were obtained at variable times postinjury. For this reason, additional factors known to modify clinical outcomes such as acute
pain, memory, and headache could not be completely considered or corrected for
statistically [64]. To account for the lack of true volumetric controls, NeuroQuant
normative percentile values were used to characterize normalcy of cortical volume. These
values are generated by comparison of subject brain volumes to a proprietary normative
database, therefore providing some insight into normalcy of volumetric findings. No such
normative database exists for WMHs. Symptoms described in this study may be
nonspecific and can be caused/influenced by factors that are non-trauma related [16, 64].
There is an inescapable ascertainment bias, in that patients who are more symptomatic
are more likely to likely to seek clinical consultation and imaging. The data analyzed in
this study should not be used to estimate the incidence of mTBI associated symptoms or
image findings.
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IV.

Results

Statistical association of Cortical Atrophy and WMH
Pearson's

Spearman's

Correlation

Rho

Frontal (Both)

-0.18

-0.10

Frontal (L)

-0.17

-0.12

Frontal (R)

-0.15

-0.24

Parietal (Both)

0.04

0.04

Parietal (L)

0.01

0.00

Parietal (R)

0.08

0.02

Occipital (Both)

-0.17

-0.04

Occipital (L)

0.09

0.04

Occipital (R)

-0.13

-0.14

Table 4: Statistical association between number of regional WMHs and NeuroQuant
normative percentile. Values closer to ± 1.00 indicate a stronger correlation (N=59) No
temporal or cerebellar WMH were present in any subjects.
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The Pearson's correlation and Spearman's Rho test values in table 4 demonstrate minimal
correlation between regional or lateral-regional white matter burden and NeuroQuant
normative percentile. This indicates minimal co-association between our quantitative
image findings, suggesting independent mechanisms for the induction of WMH
formation and cortical atrophy or that associated cortical atrophy was so regional that it
was overshadowed by the large volume of the entire lobe. Whether or not one, or both, of
these imaging findings may be related to trauma is difficult to definitively determine
without a control group. However, these image findings may still impact symptom
presentation/longevity in mTBI even if they are not traumatically induced. This notion is
substantiated

by

our

preliminary

findings

showing

an

association

between

occipital/parietal volume and longevity of cognitive/anxiety clinical outcomes.

Headaches, balance issues, and cognitive deficits were the most commonly reported
symptoms in all subgroups, and also the most likely to improve or resolve. Conversely,
emotional lability and fatigue were the two least commonly reported and also the least
likely to improve or resolve. Interval censored analysis revealed statistically significant
positive associations between WM status and longevity of post-concussive cognitive
deficits (p<0.024). Positive WM status is also nearly significant predictor of postconcussive headache longevity. These correlations are reported in table 6, and also shown
in figures 4 and 5.
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Prevalence of Symptom Presentation & Improvement in WM Subgroups
0 WMH

1 WMH

>1 WMH

Incidence Improvement Incidence Improvement Incidence
Headache

Balance

83

31

24

9

32

6

(94%)

(37.4%)

(96%)

(37.5%)

(94.1%)

(18.7%)

57

17

21

6

(64.8%)

(29.8%)

(84%)

(28.6%)

27

23

9

Cognitive 67 (76.1%)

Fatigue 10 (11.4%)

Anxiety

Depression
Emo.
Lability

Improvement

(40.3%)
1
(10.0%)

(92%)
5 (20.0%)

(39.1%)
1
(20.0%)

26 (76.5%)

4
(15.4%)
4

29 (85.3%)

10 (29.4%)

(13.8%)
0
(0%)

24

4

10

1

(27.3%)

(16.7%)

(40.0%)

(10.0%)

20

3

(22.7%)

(15.0%)

13

1

6

0

10

0

(14.8%)

(7.69%)

(24.0%)

(0%)

(29.4%)

(0%)

8 (32.0%)

1

14 (41.2%)

13 (38.2%)

(12.5%)

0
(0%)
0
(0%)

Table 5: Incidence and resolution of symptoms by number of patients in analyzed
patient population, or the % of the patient population (Note: the % patient population
under incidence is relative to the total "n" for each subgroup, % patient population for
improvement is relative to number of incidences).
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Interval Censored Symptom Survival Statistics for All Subgroups
Symptom

SE

z-value

p-value

0.42

0.5

0.921

0.53

-0.9

0.711

Cognitive

0.49

-1.6

0.361

Anxiety

2.10

0.4

0.898

Depression

1.98

-0.1

0.993

0.46

-1.1

0.115

0.49

-1.9

0.238

Cognitive

0.39

-2.1

0.092

Cortical Atrophy Headache

0.80

1.1

0.194

(With/Without) Balance

0.94

-2.4

0.267

Cognitive

0.81

-1.3

0.143

WM Status Headache

0.84

-1.3

0.090

1.08

-2.9

0.119

Cognitive

0.76

2

<0.024

WM Status Headache

0.65

-1.2

0.283

0.71

-1.0

0.215

0.85

-0.7

0.194

Sex Headache
(Male/Female) Balance

Age Headache
(<30y/>30) Balance

(With/Without) Balance

(1/>1) Balance
Cognitive

Table 6: Statistics for survival functions comparing symptom longevity among
dichotomized patient subgroups. Bootstrapped standard errors (SE), z value, and pvalues are all reported.
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Figure 4: Correlation between WMH status positive (1) or negative (0) and longevity
of post concussive headaches (p=0.090). Survival probability (y- axis) in this context is
used to indicate proportion of subjects experiencing survival of their headaches after a
given number of days (x-axis).
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Figure 5: Correlation between WMH status positive (1) or negative (0) and longevity
of post concussive cognitive deficits (p=0.024) Survival probability (y- axis) in this
context is used to indicate proportion of subjects experiencing survival of cognitive
deficits after a given number of days (x-axis).
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V.

Conclusions & Future Directions

The purpose of this study was to assess how two quantitative image findings (cortical
thinning and WMHs) co-associate with one another, and how they might independently
correlate with unfavorable clinical outcomes post-concussion. Assessment of image
finding correlation shows that white matter hyperintensities do not consistently coincide
with cortical thinning, at least as defined by the NeuroQuant normative percentile values
used in this analysis (Table 4). Further studies may use other volumetric parameters to
examine the relationship between regional white matter burden and changes in volume
in the aftermath of a concussion. One significant limitation of this study is the lack of
imaging data for multiple timepoints. Some recent studies have indicated that white
matter hyperintensities as well as cortical thinning may only be present at certain
windows of time post-concussion. A prospective longitudinal study with uniform clinical
follow up and imaging may reveal time sensitive associations between imaging findings
and clinical outcomes.

There was no statistically significant gender-based differences in symptom longevity
observed (Table 6). There were no significant differences in symptom longevity among
age dichotomized patient groups. This is consistent with recent studies reporting no
significant gender-based differences in clinical symptom presentation or longevity [65].
However, the association between age and longevity of post-concussive cognitive deficits
was approaching significance. This is not surprising, since white matter development and
structural normalcy are strongly age-dependent even in the absence of trauma. This
trend, though not statistically significant merits further investigation and is loosely
concordant with findings showing age-dependence on outcomes [25, 56]. It is possible
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that the separation of subjects into over/under 30 instead of over/under 25 age groups
may be obscuring age related effects and suppressing the significance of this finding. An
increase in sample size could allow for movement of the age threshold to over/under 25
while still maintaining adequate statistical power. The small sample size of the WMH subgrouped data did not lend itself well to statistical analysis, but follow up studies with
larger symptomological cohorts could use a matched pair test like the McNemar’s Test to
identify statistically significant differences in symptom incidence/resolution among
WMH and perhaps even cortical atrophy sub-groups.

The observed correlation between WMH positivity and prolonged cognitive deficits is
consistent with publications describing cognitive processes as reliant on complex multilobular interactions via white matter tracts [35]. Furthermore, this finding is consistent
with the results of a recent study by Tate et al. describing worsened cognitive performance
among mTBI patients with WMHs when compared to those without [10]. Other studies
have demonstrated associations between white matter changes and cognitive deficits
[66], but fundamental differences in imaging modalities and scanner specifications
prevent direct comparison to this study. Future studies studying white matter and its
relationship with cognitive issues in concussion may benefit from the use of an imaging
modality that is more sensitive to structural alterations of white matter tracts (i.e.
diffusion tensor imaging). Associations between quantitative image findings and
neuropsychological symptoms proved difficult to assess using interval censored analysis.
This was due to the small number of patients reporting depression, anxiety, and
emotional lability. A study with a larger sample size may increase the “n” of these
symptomological subsets sufficiently to be analyzed via interval censored analysis. At
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present, I am obtaining additional WM measurements from mTBI patients under 40 to
add to this existing dataset.

At the beginning of this study, I hypothesized that two trauma related image findings,
WMHs and cortical atrophy, may co-associate in a large population of mTBI patients.
Correlative assessment using two statistical methodologies demonstrated no such
association or trend. This is consistent with the 2016 pediatric population study by Bigler
et al. which described the association between focal lesions and cortical thinning as
idiosyncratic. The second prong of my hypothesis postulated that cortical thinning and
white matter status may independently correlate with unfavorable clinical outcomes was
mostly disproven, with the exception of the WMH/Cognition association. This finding
stands alongside a number of other studies which have described a relationship between
white matter integrity and cognition [5, 18, 63, 67]. From the standpoint of statistical
methodology, these findings add to the growing body of literature utilizing intervalcensored analysis to extract meaning from retrospective datasets. Future studies would
benefit strongly from a longitudinal design, with uniform imaging and clinical follow up.
Comparison of image findings to a neuroanatomically ‘normal” database should be to
confirm the validity of my findings. The observed association between a quantitative
image finding and post-concussive symptomatology is an exciting development in the
quest to establish a more objective method of mTBI diagnosis and management.
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Appendix

#R Code: WMH/Cortical Association with Symptomatology
#Packages and Setup
setwd("/Users/thkno/Desktop/Thesis2020/Analysis/R/”)
raw<-read.delim("raw clinical.txt")
install.packages("icenReg")
library(icenReg)

#Independent variables of interest: Sex, age, cortical atrophy status, WMH status

symptoms<c("HA","Balance","Cognitive","Fatigue","Anxiety","Depression","Emotional.Lability")

#Symptom Presentation
#Symptom Presentation (Sex): this section examines the association between sex and
incidence of 7 post concussive symptoms using a Fisher’s exact test

for(j in 1:length(symptoms)){
tt<-as.data.frame(cbind(raw$Sex,raw[,j+7]))
ttab<-table(tt[complete.cases(tt),])
temp<-fisher.test(ttab)
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print(c(sum(ttab[1,])-ttab[1,length(ttab[1,])], ttab[1,length(ttab[1,])],sum(ttab[2,])ttab[2,length(ttab[2,])],
ttab[2,length(ttab[2,])],temp$estimate,temp$conf.int,temp$p.value))
}

#Symptom Presentation (Age): this section examines the association between age and
incidence of 7 post concussive symptoms with a dichotomous age variable (greater
than/less than or equal to 30) using a Fisher’s exact test

raw$Age30<-as.data.frame(ifelse(raw$Age<=30,"aLE30","zGT30"))
for(j in 1:length(symptoms)){
tt<-as.data.frame(cbind(raw$Age30,raw[,j+7]))
ttab<-table(tt[complete.cases(tt),])
#print(levels(raw$Age30))
temp<-fisher.test(ttab)
print(c(sum(ttab[1,])-ttab[1,length(ttab[1,])], ttab[1,length(ttab[1,])],sum(ttab[2,])ttab[2,length(ttab[2,])],
ttab[2,length(ttab[2,])],temp$estimate,temp$conf.int,temp$p.value))
}

#Symptom Presentation (Cortical Atrophy): this section examines the association
between cortical atrophy and presentation of 7 post concussive symptoms with a
dichotomous cortical atrophy variable (1=positive, 0=negative) using a Fisher’s exact
test
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for(j in 1:length(symptoms)){
tt<-as.data.frame(cbind(raw$ATROPHY,raw[,j+7]))
ttab<-table(tt[complete.cases(tt),])
#print(levels(raw$ATROPHY))
temp<-fisher.test(ttab)
print(c(sum(ttab[1,])-ttab[1,length(ttab[1,])], ttab[1,length(ttab[1,])],sum(ttab[2,])ttab[2,length(ttab[2,])],
ttab[2,length(ttab[2,])],temp$estimate,temp$conf.int,temp$p.value))
}

#Symptom Presentation (WMH): this section examines the association between WM
status and incidence of 7 post concussive symptoms with a dichotomous WMH
variable (1=positive, 0=negative) using a Fisher’s exact test

raw$WMH.1.[raw$WMH.1.==""]<-NA
for(j in 1:length(symptoms)){
tt<-as.data.frame(cbind(raw$WMH.1.,raw[,j+7]))
ttab<-table(tt[complete.cases(tt),])
#print(levels(raw$WMH.1.))
temp<-fisher.test(ttab)
print(c(sum(ttab[1,])-ttab[1,length(ttab[1,])], ttab[1,length(ttab[1,])],sum(ttab[2,])ttab[2,length(ttab[2,])],
ttab[2,length(ttab[2,])],temp$estimate,temp$conf.int,temp$p.value))
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}
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#Symptom Longevity

#Model assessment: First I had to decide if my data should be analyzed using a nonparametric, semi-parametric, or parametric model. I made this decision based off
sample size, bias assessment, and the general data distribution
pdf("Overall symptoms parametric vs nonparametric graphs2.pdf")
for(k in 1:7){
tint<-raw[complete.cases(cbind(raw[,k+17],raw[,k+24])),c(k+17,k+24)]
ha.mod.par<-ic_par(cbind(tint[,1],tint[,2])~1,data=raw)
diag_baseline(ha.mod.par) }
dev.off()

#I went with semi-parametric given the small sample size, and large number of rightcensored items. All parametric models demonstrated a visually poor fit.
#These loops compare all independent variables of interest, compare them to the 7
symptoms, and return the output from the interval-censored analysis.
pdf("Overall symptoms graphs2.pdf")
for(k in 1:7){
temp<-raw[complete.cases(as.data.frame(raw[,c((k+17),(k+24))])),c((k+17),(k+24))]
all.data<-ic_sp(cbind(temp[,1],temp[,2])~1)
plot(all.data,ylab="Proportion of Patients Presenting Symptom",xlab="Days Since
Injury", main=symptoms[k],lwd=2)
}
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dev.off()

#Symptom Longevity (Sex): this section examines the association between sex and
longevity of 7 post concussive symptoms using a right censored interval censored
analysis

for.plot<-data.frame(Sex=c("F","M"))
row.names(for.plot)<-c("F","M")
symptoms<c("HA","Balance","Cognitive","Fatigue","Anxiety","Depression","Emotional.Lability")
pdf("Sex clinical symptoms graphs.pdf")
for(j in 1:7){
ww<-raw[complete.cases(cbind(raw$Sex,raw[,(j+17)],raw[,(j+24)])),]
temp<-ic_sp(cbind(ww[,(j+17)],ww[,(j+24)])~Sex,data=ww,bs_samples=100)
plot(temp,for.plot,ylab="Proportion of Patients Presenting Symptom",xlab="Days Since
Injury", main=symptoms[j],lwd=2)
print(cbind(symptoms[j],Female=getSCurves(temp,for.plot)$S_curves$'F',Male=getSC
urves(temp,for.plot)$S_curves$'M',getSCurves(temp,for.plot)$'Tbull_ints'))
print(summary(temp))
}
dev.off()
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#Symptom Longevity (Age): this section examines the association between age and
longevity of 7 post concussive symptoms using a right censored interval censored
analysis
#For <=30 cut-off (0 for <=30, 1 for >30)
raw$Age30<-as.factor(ifelse(raw$Age<=30,"0","1"))
for.plot<-data.frame(Age30=c("0","1"))
row.names(for.plot)<-c("0","1")
symptoms<c("HA","Balance","Cognitive","Fatigue","Anxiety","Depression","Emotional.Lability")
pdf("Age30 clinical symptoms graphs2.pdf")
for(j in 1:7){
ww<-raw[complete.cases(cbind(raw$Age30,raw[,(j+17)],raw[,(j+24)])),]
temp<-ic_sp(cbind(ww[,(j+17)],ww[,(j+24)])~Age30,data=ww,bs_samples=100)
plot(temp,for.plot,ylab="Proportion of Patients Presenting Symptom",xlab="Days Since
Injury", main=symptoms[j],lwd=2)
print(cbind(symptoms[j], "0"=getSCurves(temp,for.plot)$S_curves$'0',
"1"=getSCurves(temp,for.plot)$S_curves$'1',getSCurves(temp,for.plot)$'Tbull_ints'))
print(summary(temp))
}
dev.off()

#Symptom Longevity (Cortical Atrophy): this section examines the association
between regional atrophy and longevity of 7 post concussive symptoms using a right
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censored interval censored analysis with a with a dichotomous cortical atrophy
variable (1=positive, 0=negative)

for.plot<-data.frame(ATROPHY=c("0","1"))
row.names(for.plot)<-c("0","1")
symptoms<c("HA","Balance","Cognitive","Fatigue","Anxiety","Depression","Emotional.Lability")
pdf("ATROPHY clinical symptoms graphs.pdf")
for(j in 1:7){
ww<-raw[complete.cases(cbind(raw$ATROPHY,raw[,(j+17)],raw[,(j+24)])),]
temp<ic_sp(cbind(ww[,(j+17)],ww[,(j+24)])~as.factor(ATROPHY),data=ww,bs_samples=100
)
plot(temp,for.plot,ylab="Proportion of Patients Presenting Symptom",xlab="Days Since
Injury", main=symptoms[j],lwd=2)
print(cbind(symptoms[j], "0 "=getSCurves(temp,for.plot)$S_curves$'0', "1
"=getSCurves(temp,for.plot)$S_curves$'1',getSCurves(temp,for.plot)$'Tbull_ints'))
print(summary(temp))
}
dev.off()

#Symptom Longevity (WMH): this section examines the association between WM
positivity/negativity and longevity of 7 post concussive symptoms using a right
censored interval censored analysis
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for.plot<-data.frame(WMH.1.= c("Positive","Negative"))
row.names(for.plot)<-c("Positive","Negative")
symptoms<c("HA","Balance","Cognitive","Fatigue","Anxiety","Depression","Emotional.Lability")
pdf("WMH.1. clinical symptoms graphs3.pdf")
for(j in 1:7){
ww<-raw[complete.cases(cbind(raw$ WMH.1.,raw[,(j+17)],raw[,(j+24)])),]
temp<-ic_sp(cbind(ww[,(j+17)],ww[,(j+24)])~ WMH.1.,data=ww,bs_samples=100)
#plot(temp,for.plot,ylab="Proportion of Patients Presenting Symptom",xlab="Days
Since Injury", main=symptoms[j],lwd=2)
print(cbind(symptoms[j], "zPositive"=getSCurves(temp,for.plot)$S_curves$'0',
"Negative"=getSCurves(temp,for.plot)$S_curves$'1',getSCurves(temp,for.plot)$'Tbull_i
nts'))
print(summary(temp))
}
dev.off()

#Symptom Longevity (WMH): this section examines the association between
multiple/single WMH burden and longevity of 7 post concussive symptoms using a right
censored interval censored analysis

for.plot<-data.frame(WMH.2.= c("Mult","Sing"))
row.names(for.plot)<-c("Mult","Sing")
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symptoms<c("HA","Balance","Cognitive","Fatigue","Anxiety","Depression","Emotional.Lability")
pdf("WMH.2. clinical symptoms graphs3.pdf")
for(j in 1:7){
ww<-raw[complete.cases(cbind(raw$ WMH.2.,raw[,(j+17)],raw[,(j+24)])),]
temp<-ic_sp(cbind(ww[,(j+17)],ww[,(j+24)])~ WMH.2.,data=ww,bs_samples=100)
#plot(temp,for.plot,ylab="Proportion of Patients Presenting Symptom",xlab="Days
Since Injury", main=symptoms[j],lwd=2)
print(cbind(symptoms[j], "zMult"=getSCurves(temp,for.plot)$S_curves$'0',
"Sing"=getSCurves(temp,for.plot)$S_curves$'1',getSCurves(temp,for.plot)$'Tbull_ints')
)
print(summary(temp))
}
dev.off()
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#Graphs for Manuscript
#For sex comparison
for.plot<-data.frame(Sex=c("F","M"))
row.names(for.plot)<-c("F","M")
symptoms<c("Headache","Balance","Cognitive","Fatigue","Anxiety","Depression","Emotional
Lability")
pdf("Sex clinical symptoms graphs pub.pdf")
for(j in 1:7){
ww<-raw[complete.cases(cbind(raw$Sex,raw[,(j+17)],raw[,(j+24)])),]
temp<-ic_sp(cbind(ww[,(j+17)],ww[,(j+24)])~Sex,data=ww)
plot(temp,for.plot,ylab="Proportion of Patients Presenting Symptom",xlab="Days Since
Injury", main=symptoms[j],lwd=2,cex.lab=1.3,col=c(17,24))
}
dev.off()

#For atrophy comparison
for.plot<-data.frame(ATROPHY=c("0","1"))
row.names(for.plot)<-c("ATROPHY=0","ATROPHY=1")
pdf("ATROPHY clinical symptoms graphs pub.pdf")
for(j in 1:7){
ww<-raw[complete.cases(cbind(raw$ATROPHY,raw[,(j+17)],raw[,(j+24)])),]
temp<-ic_sp(cbind(ww[,(j+17)],ww[,(j+24)])~as.factor(ATROPHY),data=ww)
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plot(temp,for.plot,ylab="Proportion of Patients Presenting Symptom",xlab="Days Since
Injury", main=symptoms[j],lwd=2,cex.lab=1.3,col=c(17,24))
}
dev.off()

#For age comparison (0 for <=30, 1 for >30)
raw$Age30<-as.factor(ifelse(raw$Age<=30,"0","1"))
for.plot<-data.frame(Age30=c("0","1"))
row.names(for.plot)<-c("<30",">30")
pdf("Age30 clinical symptoms graphs pub.pdf")
for(j in 1:7){
ww<-raw[complete.cases(cbind(raw$Age30,raw[,(j+17)],raw[,(j+24)])),]
temp<-ic_sp(cbind(ww[,(j+17)],ww[,(j+24)])~Age30,data=ww)
plot(temp,for.plot,ylab="Proportion of Patients Presenting Symptom",xlab="Days Since
Injury", main=symptoms[j],lwd=2,cex.lab=1.3,col=c(17,24))
}
dev.off()

#For WMH comparison
for.plot<-data.frame(WMH.1.= c("0","1"))
row.names(for.plot)<-c("WMH (-)","WMH (+)")
pdf("MRI clinical symptoms graphs pub2.pdf")
for(j in 1:7){
ww<-raw[complete.cases(cbind(raw$ WMH.1.,raw[,(j+17)],raw[,(j+24)])),]
46

temp<-ic_sp(cbind(ww[,(j+17)],ww[,(j+24)])~ WMH.1.,data=ww,bs_samples=100)
plot(temp,for.plot,ylab="Proportion of Patients Presenting Symptom",xlab="Days Since
Injury", main=symptoms[j],lwd=2,cex.lab=1.3,col=c(17,24))
}
dev.off()
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